While clinical trial results are being released regarding drugs intended to decrease amyloid production - thought to contribute to decline in Alzheimer's disease - clinical trials of drugs targeting other disease proteins, such as tau, are in their initial phases.
Perelman School of Medicine
Cliff Deutschman of the Perelman School of Medicine is quoted about treating blood poisoning.
Thomas Wadden of the Perelman School of Medicine says, "Dieters should expect as much from themselves as they do from medications."
Carl June of the Perelman School of Medicine and Nicola Mason of the School of Veterinary Medicine comment on how dogs can help in human-cancer research.
A snippet of an online course taught by Ezekiel Emanuel of the Perelman School of Medicine and the Wharton School is highlighted.
Ran Reshef, David Porter, Robert Vonderheide and Carl June of the Perelman of School of Medicine are highlighted for their contributions to cancer-treatment research.
Steven Arnold of the Perelman School of Medicine talks about how much there is to learn from genetic Alzheimer’s.
Joseph Harryhill of the Perelman School of Medicine comments on weighing the risks and benefits of a hair-loss drug.